ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option

Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF109KC1GG4

NAV · 06-Jul-2026

₹25.4300

+6.54%

+9.05%

1Y (CAGR)

+0.55%

3Y (CAGR)

+15.44%

5Y (CAGR)

+6.01%

Since inception (CAGR)

+12.57%

NAV history

hover for values

Risk & SIP analytics

Q2 · 3Y in category

Volatility (3y)

16.00%

Downside dev (3y)

15.23%

Max drawdown (3y)

-19.6%

Sharpe (3y)

0.56

SIP XIRR (3y)

+10.18%

SIP XIRR (5y)

+12.17%

Calendar-year returns

2020 +56.6%2021 +7.3%2022 -16.6%2023 +29.2%2024 +36.3%2025 -9.0%

Fund facts

Fund managerDharmesh Kakkad · Sharmila D’mello

AUM₹64,535 Cr

TER · AMFI officialDirect 1.31% · Regular 2.10% (2026-06-30)

Launch date25-Jun-2018

Plan typeOpen Ended · Equity

Min lumpsumRs. 5000/- (plus in multiple of Re. 1)

Lock-inNone

Volatility16.74

AMCICICI Prudential Asset Management Company Limited

Objective · To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.

scheme documents ↗